Herb Profile

Boldo

Peumus boldus

Boldo (Peumus boldus) carries a Grade C rating — limited evidence.

Last reviewed: 3 sources citedReport a correctionProfile-wide ·C Limited

Use extra caution Avoid high dose or prolonged internal use; alkaloid/essential oil rich preparations may irritate the GI tract and are inappropriate in pregnancy, liver disease, or bile duct obstruction. Details

Evidence
Limited Evidence
Typical onset
Varies by prep
Safety rating
High caution
Best for
Digestive
Avoid / review if
Pregnancy Or Breastfeeding Without Clinician Guidance
Boldo monograph visual
Generated profile category visual

At a glance

From this profile's structured data
Evidence
Grade C
Safety
Avoid high-dose or prolonged internal use; alkaloid/essential-oil rich preparations may irritate the GI tract and are inappropriate in pregnancy, liver disease, or bile-duct obstruction.
Profile context
digestive
Next steps

Continue reading

  • If you want to browse more herbsAll herbs

Safety

Safety & Cautions

Avoid high dose or prolonged internal use; alkaloid/essential oil rich preparations may irritate the GI tract and are inappropriate in pregnancy, liver disease, or bile duct obstruction.

High caution

Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.

  • Interaction-AwareMedication or interaction context is explicitly noted.
  • Liver-SensitiveLiver-related caution language appears in the profile.
  • Anticoagulant CautionBleeding or anticoagulant-adjacent caution language is present.
  • Pregnancy/Breastfeeding CautionPregnancy or breastfeeding caution language is present.
Detailed safety fields

Pregnancy, breastfeeding, and contraindications

  • Pregnancy Or Breastfeeding Without Clinician Guidance

Safety classifications

  • Interaction-Aware: Medication or interaction context is explicitly noted.
  • Liver-Sensitive: Liver-related caution language appears in the profile.
  • Anticoagulant Caution: Bleeding or anticoagulant-adjacent caution language is present.
  • Pregnancy/Breastfeeding Caution: Pregnancy or breastfeeding caution language is present.

Full safety note

  • Avoid high dose or prolonged internal use; alkaloid/essential oil rich preparations may irritate the GI tract and are inappropriate in pregnancy, liver disease, or bile duct obstruction.

Safety labels

  • Interaction-Aware
  • Liver-Sensitive
  • Anticoagulant Caution
  • Pregnancy/Breastfeeding Caution

Evidence-based safety

Caution when combined

Severity and certainty are shown separately. A high-priority caution can still be theoretical: these pairings are screened from shared contraindication mechanisms and are not automatically documented clinical interactions. Provenance identifies the source fields that produced each flag; it does not upgrade the certainty of the pairwise claim.

Evidence

Evidence Summary

Evidence lens

Read as directional context, not settled clinical proof.

LimitedLimited Evidence

Human clinical evidence: Not the primary signal

Mechanistic / preclinical: Mechanism mappedDigestive Support · Hepatobiliary Support

Research maturity: Theoretical / mechanistic researchMechanistic or unresolved evidence is kept separate from established human outcomes.

Safety boundary: Safety note availableAvoid high dose or prolonged internal use; alkaloid/essential oil rich preparations may irritate the GI tract and are inappropriate in pregnancy, liver disease, or bile duct obstruction.

This profile cites 3 human studies.

Study design details
Evidence Grade

Grade C: Limited Evidence

Evaluation of methodological rigor, population reach, and evidence alignment.

Design Match
Narrative review
Risk of Bias
High
Consistency
Not assessed
Strongest recorded design is a narrative review, drawn from 1 recorded study, none of which measured an outcome in people.
How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

Strong
Multiple RCTs, consistent direction, adequate effect size
Moderate
Some RCTs or consistent observational data in humans
Preliminary / Mixed
Animal or in-vitro only, or conflicting human data
Traditional / Theoretical
Traditional use only; no controlled human trials
Clinical Study Summaries (3)0 human evidence sources · 0 human trials · Participant totals not consistently reported · Consistency not yet classifiable

Filter by study class

Showing 3 of 3 studies.

What the evidence actually shows

This table contains 3 structured sources, including 0 human evidence sources; 0 are human trials. A reliable participant total cannot be calculated because sample size is not consistently structured in the cited sources. Source-to-conclusion relationships are not classified in this structured set, so consistency is not yet classifiable.

Profile-wide evidence grade: see the profile grade above · Confidence: not separately assigned

What would change our conclusion?

Larger, well-controlled human trials using comparable populations, doses, preparations, and clinically meaningful outcomes could materially strengthen or weaken this conclusion. Replication in a different population or a high-quality synthesis resolving current disagreement could also materially change confidence.

StudyDesignNDoseDurationPopulationOutcomeResult & magnitudeSource

Tacrolimus and herbs interactions: a review

Abushammala I et al. · Pharmazie · 2021

Background
Narrative review

Summarizes selected literature without the full prespecified search and selection methods of a systematic review.

PubMed

Boldo leaves reduce seizures, neuroinflammation, and hemichannel activity in a murine model of chronic epilepsy

García-Rodríguez C et al. · Biol Res · 2025

Background
Other / unclear

The study design is not yet classified clearly enough to infer its place in the evidence hierarchy.

PubMed

Peumus boldus Extract Inhibits Lipid Accumulation in 3T3-L1 Adipocytes

Montaldo L et al. · Int J Mol Sci · 2025

Background
Other / unclear

The study design is not yet classified clearly enough to infer its place in the evidence hierarchy.

PubMed

Dosing & Timing

No standardized dose
Preparation specific; use standardized product label for Aromatic herb/spice forms and essential oils differ greatly and require source backed dosage review before therapeutic claims.
How Boldo works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Boldo Works

How Boldo WorksBoldo acts on biological target pathways via digestive support, leading to digestive.BoldoBiological TargetBiological pathwayDigestive SupportDigestiveObservable outcomeHepaticDetoxification
CompoundTarget / ReceptorMechanismEffect / Outcome
Mechanisms & biological pathways

Preclinical pathways. Proposed mechanisms from in vitro and animal research; these do not confirm clinical outcomes in humans.

  • Digestive Support
  • Hepatobiliary Support

Compare related active botanicals

Explore botanicals with similar chemistry, effects, or safety considerations in the Botanical Activity Atlas.

Guides that use Boldo

Condition guides

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Help improve this profile

Was this useful for your research?

These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.

Was this evidence summary clear?

Did you find what you were researching?

Free safety checklist

Get the Boldo research notes

Evidence summaries, dosing context, and safety updates for this herb — straight to your inbox.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.

Botanical profile context

How to interpret Boldo

Boldo herb profile with evidence context, key research topics, source notes, safety context, and references presented in an evidence-first format. Use this herb profile as a starting point for evidence review, not as a recommendation to start a new supplement. Botanical products can vary by plant part, extract ratio, standardization, dose, and contaminant testing, so two labels with the same common name may not behave the same way.

When reviewing Boldo, compare the traditional-use context against the human evidence, mechanism notes, and safety cautions. Pay special attention to pregnancy, breastfeeding, liver or kidney disease, blood-pressure effects, sedation, stimulation, anticoagulant use, antidepressants, and any prescription medication overlap.

For product decisions, prefer transparent labels, named extracts, clear serving sizes, and third-party quality testing. Avoid treating a long list of possible mechanisms as proof that an herb will solve a specific condition.